Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gonyautoxin 2/3 in the Treatment of Acute Back Pain (Study No CLN 17-032): A Clinical Proof-of-concept Study

NCT04799041 is registered in ClinicalTrials.gov with Algenis SpA as lead sponsor.

NCT NCT04799041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04799041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gonyautoxin 2/3 in the Treatment of Acute Back Pain (Study No CLN 17-032): A Clinical Proof-of-concept Study
Lead sponsor
Algenis SpA
Phase
Phase 1/2
Overall status
Completed
Start date
October 11, 2019
Completion date
March 19, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, back pain